Trial Profile
Phase II trial of letermovir compared with valganciclovir in transplant recipients with human cytomegalovirus viraemia post-transplantation
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Oct 2009
Price :
$35
*
At a glance
- Drugs Letermovir (Primary) ; Valganciclovir
- Indications Cytomegalic inclusion disorders; Cytomegalovirus infections
- Focus Therapeutic Use
- 15 Sep 2009 New trial record
- 15 Sep 2009 Results presented at the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) 2009